Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(7)
MIXED(5)
laboratory biomarker analysis
3 trials
phase_1
national-cancer-institute-nci, university-of-chicago
cytarabine
2 trials
phase_1
national-cancer-institute-nci, university-of-chicago
Azacitidine
2 trials
phase_1
national-cancer-institute-nci, university-of-chicago
mitoxantrone hydrochloride
1 trial
phase_1
university-of-chicago
triapine
1 trial
phase_1
national-cancer-institute-nci
selumetinib
1 trial
phase_2
national-cancer-institute-nci
Belinostat
1 trial
phase_1
national-cancer-institute-nci
romidepsin
1 trial
phase_2
national-cancer-institute-nci
8 unique interventions2 categories

Analytics

Trial Phases

Phase 13
Phase 22

Trial Status

Completed5

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT01839240Phase 1Completed
Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+14 more
PrincipalinvestigatorStart date: 2012-06-06
NCT00062075Phase 2Completed
Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
Principalinvestigator
NCT00077181Phase 1Completed
3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)+8 more
Principalinvestigator
NCT00351975Phase 1Completed
Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases
Accelerated Phase of DiseaseAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+17 more
Principalinvestigator
NCT00588809Phase 2Completed
Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia
Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Promyelocytic Leukemia (M3)Myelodysplastic Syndromes+3 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Tapan M Kadia

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Secondary Acute Myeloid Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndromes+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicMyelodysplastic/Myeloproliferative Neoplasms+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Leukemia, Myelomonocytic, ChronicMyelodysplastic SyndromesPrimary Myelofibrosis
Similarity Score2%

Mario Sznol, MD

Vion Pharmaceuticals

Related
14 trials

Shared therapeutic areas:

Myelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Stuart A. Grossman, MD

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Related
13 trials

Shared therapeutic areas:

Myelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Primary MyelofibrosisRecurrent Adult Acute Myeloid Leukemia

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Myelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Myelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Myelodysplastic Syndromes
Similarity Score1%

Gregory Reid, MSc, MBA

MethylGene Inc.

Related
13 trials

Shared therapeutic areas:

Myelodysplastic Syndromes
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT01839240Phase 1PrincipalInvestigator

Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia

Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+14 more
Completed
NCT00062075Phase 2PrincipalInvestigator

Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
Completed
NCT00077181Phase 1PrincipalInvestigator

3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies

Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)+8 more
Completed
NCT00351975Phase 1PrincipalInvestigator

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

Accelerated Phase of DiseaseAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+17 more
Completed
NCT00588809Phase 2PrincipalInvestigator

Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia

Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Promyelocytic Leukemia (M3)Myelodysplastic Syndromes+3 more
Completed

All 5 trials loaded